The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia. 1992

M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
Gastroenterology Department, Hospital General del Oeste, Caracas, Venezuela.

Vasoactive intestinal polypeptide (VIP) is one of the main neurotransmitters implicated in the relaxation of the lower esophageal sphincter (LES). The effect of exogenous VIP on LES motor activity was determined by esophageal manometry. LES pressure (LESP) and LES relaxation were compared in four healthy volunteers and in six patients with achalasia. The effects of intravenous doses of 1.5, 3, and 5 pmol.kg-1.min-1 of VIP were compared with placebo. Neither placebo nor 3 and 5 pmol.kg-1.min-1 of VIP produced any effect on esophageal motility in healthy volunteers. In achalasia the three doses of VIP caused a dose-dependent decrease in LESP with a significant improvement in LES relaxation. A dose of 5 pmol.kg-1.min-1 produced a maximal decrease of 51% in LESP. A beta-adrenergic agonist, isoproterenol, caused a decrease in LESP both in healthy volunteers and in patients with achalasia without improving LES relaxation. In summary, intravenous VIP improved LES relaxation and caused a decrease in LESP in patients with achalasia without affecting LESP in healthy volunteers, indicating that the LES muscle in achalasia is supersensitive to VIP. The current study suggests that a selective damage in the noncholinergic nonadrenergic innervation of the esophagus is in part responsible for the motor alteration seen in these patients. The findings and the inability of isoproterenol to improve LES relaxation despite decreasing LESP support a role in VIP as a indicator of LES relaxation.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D011312 Pressure A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Pressures
D004931 Esophageal Achalasia A motility disorder of the ESOPHAGUS in which the LOWER ESOPHAGEAL SPHINCTER (near the CARDIA) fails to relax resulting in functional obstruction of the esophagus, and DYSPHAGIA. Achalasia is characterized by a grossly contorted and dilated esophagus (megaesophagus). Achalasia, Esophageal,Cardiospasm,Megaesophagus,Achalasia,Achalasias,Achalasias, Esophageal,Cardiospasms,Esophageal Achalasias
D004943 Esophagogastric Junction The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice. Gastroesophageal Junction,Gastroesophageal Junctions,Junction, Esophagogastric,Junction, Gastroesophageal,Junctions, Gastroesophageal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
March 1974, Zeitschrift fur Gastroenterologie,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
April 1984, The Journal of clinical investigation,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
November 1979, Gastroenterology,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
May 1983, Gastroenterology,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
November 1993, Gastroenterology,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
November 1980, Pharmacological research communications,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
May 1979, Digestive diseases and sciences,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
December 1991, Gastroenterologia Japonica,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
May 1998, The Journal of pharmacology and experimental therapeutics,
M Guelrud, and A Rossiter, and P F Souney, and G Rossiter, and J Fanikos, and V Mujica
December 1971, Gastroenterology,
Copied contents to your clipboard!